Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$3.88 USD
+0.02 (0.52%)
Updated Sep 18, 2024 04:00 PM ET
Pre-Market: $4.04 +0.16 (4.12%) 8:22 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
Editas Medicine, Inc. [EDIT]
Reports for Purchase
Showing records 1 - 20 ( 105 total )
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for EDIT 112123
Provider: Stock Traders Daily
Analyst: Research Department